Physician profile
Dena Bartley
NPI 1346713260
$396.70
in general payments reported to CMS, 2019-2025
12 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.82 · 2023: $71.59 · 2024: $150 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.26 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $70.22 | 2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.51 | 2021-2024 | Jardiance |
| Abbvie INC. | $59.08 | 2021-2024 | |
| Lilly USA, LLC | $34.20 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.81 | 2023 | |
| Janssen Biotech, INC. | $24.61 | 2024 | Tremfya |
| Lundbeck LLC | $19.97 | 2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $17.49 | 2024 | Truxima |
| Abbott Laboratories | $17.36 | 2024 | Freestyle Libre 3 |
| Amgen INC. | $17.00 | 2024 | Repatha, Otezla |
| Exact Sciences Corporation | $16.93 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $16.52 | 2023 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dena Bartley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.